Takeda Pharmaceutical Co logo

TAK - Takeda Pharmaceutical Co Share Price

$20.01 -0.1  -0.2%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £48.20bn
Enterprise Value £79.41bn
Revenue £20.08bn
Position in Universe 170th / 6410
Bullish
Bearish
Unlock TAK Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

TAK Revenue Unlock TAK Revenue

Net Income

TAK Net Income Unlock TAK Revenue

Normalised EPS

TAK Normalised EPS Unlock TAK Revenue

PE Ratio Range

TAK PE Ratio Range Unlock TAK Revenue

Dividend Yield Range

TAK Dividend Yield Range Unlock TAK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TAK EPS Forecasts Unlock TAK Revenue
Profile Summary

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Directors
Last Annual March 31st, 2019
Last Interim September 30th, 2019
Incorporated January 29, 1925
Public Since May 16, 1949
No. of Shareholders: 327,577
No. of Employees: 49,578
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange New York Stock Exchange (Dual Listing)
Shares in Issue 3,115,493,244
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TAK Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TAK
Upcoming Events for TAK
Thursday 30th January, 2020 Estimate
Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Release
Tuesday 4th February, 2020
Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call (Japanese)
Tuesday 4th February, 2020
Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call
Tuesday 4th February, 2020
Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session
Monday 30th March, 2020
Dividend For 4502.T
Tuesday 12th May, 2020 Estimate
Full Year 2020 Takeda Pharmaceutical Co Ltd Earnings Release
Friday 26th June, 2020 Estimate
Takeda Pharmaceutical Co Ltd Annual Shareholders Meeting
Similar to TAK
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.